Influence of pharmacologic intervention and valvular heart disease on left ventricular ejection phase indices: a review.
Echocardiography represents an established noninvasive technique to evaluate left ventricular (LV) performance. The LV ejection phase indices may be divided into three categories: (1) volume-dependent, (2) circumferential, and (3) wall thickening. Since the latter two are not volume dependent, they are clinically more useful in patients with dilated left ventricles. These parameters have limited clinical value in the presence of left-sided volume overload conditions (e g, mitral regurgitation and aortic regurgitation) since significant LV dysfunction may exist in the presence of normal ejection phase indices by echo. The echocardiogram is also a sensitive procedure to detect subtle alterations in LV function following acute or chronic interventions with various types of vasoactive and inotropic drugs.
D000293:Adolescent; D000328:Adult; D000777:Anesthetics / Q000009:adverse effects; D002648:Child; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D004452:Echocardiography; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000503:physiopathology*; D006352:Heart Ventricles; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D013318:Stroke Volume / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D000777:Anesthetics; D004071:Digitalis Glycosides; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents